267 related articles for article (PubMed ID: 16457965)
1. Noninvasive monitoring of radiotherapy-induced microvascular changes using dynamic contrast enhanced magnetic resonance imaging (DCE-MRI) in a colorectal tumor model.
Ceelen W; Smeets P; Backes W; Van Damme N; Boterberg T; Demetter P; Bouckenooghe I; De Visschere M; Peeters M; Pattyn P
Int J Radiat Oncol Biol Phys; 2006 Mar; 64(4):1188-96. PubMed ID: 16457965
[TBL] [Abstract][Full Text] [Related]
2. PTK787/ZK222584, a tyrosine kinase inhibitor of vascular endothelial growth factor receptor, reduces uptake of the contrast agent GdDOTA by murine orthotopic B16/BL6 melanoma tumours and inhibits their growth in vivo.
Rudin M; McSheehy PM; Allegrini PR; Rausch M; Baumann D; Becquet M; Brecht K; Brueggen J; Ferretti S; Schaeffer F; Schnell C; Wood J
NMR Biomed; 2005 Aug; 18(5):308-21. PubMed ID: 15918178
[TBL] [Abstract][Full Text] [Related]
3. Assessment of neovascular permeability in a pancreatic tumor model using dynamic contrast-enhanced (DCE) MRI with contrast agents of different molecular weights.
Delrue LJ; Casneuf V; Van Damme N; Blanckaert P; Peeters M; Ceelen WP; Duyck PC
MAGMA; 2011 Aug; 24(4):225-32. PubMed ID: 21567161
[TBL] [Abstract][Full Text] [Related]
4. Dynamic contrast-enhanced MRI in mouse tumors at 11.7 T: comparison of three contrast agents with different molecular weights to assess the early effects of combretastatin A4.
Fruytier AC; Magat J; Neveu MA; Karroum O; Bouzin C; Feron O; Jordan B; Cron GO; Gallez B
NMR Biomed; 2014 Nov; 27(11):1403-12. PubMed ID: 25323069
[TBL] [Abstract][Full Text] [Related]
5. Dynamic contrast-enhanced (DCE) MRI assessment of microvascular characteristics in the murine orthotopic pancreatic cancer model.
Wu L; Lv P; Zhang H; Fu C; Yao X; Wang C; Zeng M; Li Y; Wang X
Magn Reson Imaging; 2015 Jul; 33(6):737-60. PubMed ID: 25169584
[TBL] [Abstract][Full Text] [Related]
6. Correlations of 3T DCE-MRI quantitative parameters with microvessel density in a human-colorectal-cancer xenograft mouse model.
Ahn SJ; An CS; Koom WS; Song HT; Suh JS
Korean J Radiol; 2011; 12(6):722-30. PubMed ID: 22043155
[TBL] [Abstract][Full Text] [Related]
7. Dynamic Contrast-Enhanced MRI Using a Macromolecular MR Contrast Agent (P792): Evaluation of Antivascular Drug Effect in a Rabbit VX2 Liver Tumor Model.
Park HS; Han JK; Lee JM; Kim YI; Woo S; Yoon JH; Choi JY; Choi BI
Korean J Radiol; 2015; 16(5):1029-37. PubMed ID: 26357497
[TBL] [Abstract][Full Text] [Related]
8. Perfusion parameters of dynamic contrast-enhanced magnetic resonance imaging in patients with rectal cancer: correlation with microvascular density and vascular endothelial growth factor expression.
Kim YE; Lim JS; Choi J; Kim D; Myoung S; Kim MJ; Kim KW
Korean J Radiol; 2013; 14(6):878-85. PubMed ID: 24265562
[TBL] [Abstract][Full Text] [Related]
9. Quantitative dynamic contrast-enhanced MRI in tumor-bearing rats and mice with inversion recovery TrueFISP and two contrast agents at 4.7 T.
Weidensteiner C; Rausch M; McSheehy PM; Allegrini PR
J Magn Reson Imaging; 2006 Sep; 24(3):646-56. PubMed ID: 16878308
[TBL] [Abstract][Full Text] [Related]
10. Dynamic contrast-enhanced magnetic resonance imaging of radiation therapy-induced microcirculation changes in rectal cancer.
de Lussanet QG; Backes WH; Griffioen AW; Padhani AR; Baeten CI; van Baardwijk A; Lambin P; Beets GL; van Engelshoven JM; Beets-Tan RG
Int J Radiat Oncol Biol Phys; 2005 Dec; 63(5):1309-15. PubMed ID: 16125874
[TBL] [Abstract][Full Text] [Related]
11. Comparison of dynamic contrast-enhanced magnetic resonance imaging and contrast-enhanced ultrasound for evaluation of the effects of sorafenib in a rat model of hepatocellular carcinoma.
Muñoz NM; Minhaj AA; Maldonado KL; Kingsley CV; Cortes AC; Taghavi H; Polak U; Mitchell JM; Ensor JE; Bankson JA; Rashid A; Avritscher R
Magn Reson Imaging; 2019 Apr; 57():156-164. PubMed ID: 30465870
[TBL] [Abstract][Full Text] [Related]
12. Noninvasive monitoring of microvascular changes with partial irradiation using dynamic contrast-enhanced and blood oxygen level-dependent magnetic resonance imaging.
Lin YC; Wang JJ; Hong JH; Lin YP; Lee CC; Wai YY; Ng SH; Wu YM; Wang CC
Int J Radiat Oncol Biol Phys; 2013 Apr; 85(5):1367-74. PubMed ID: 23195777
[TBL] [Abstract][Full Text] [Related]
13. The value of DCE-MRI in assessing histopathological and molecular biological features in induced rat epithelial ovarian carcinomas.
Yuan SJ; Qiao TK; Qiang JW; Cai SQ; Li RK
J Ovarian Res; 2017 Sep; 10(1):65. PubMed ID: 28950890
[TBL] [Abstract][Full Text] [Related]
14. Combining dynamic contrast enhanced magnetic resonance imaging and microvessel density to assess the angiogenesis after PEI in a rabbit VX2 liver tumor model.
Chen J; Qian T; Zhang H; Wei C; Meng F; Yin H
Magn Reson Imaging; 2016 Feb; 34(2):177-82. PubMed ID: 26518059
[TBL] [Abstract][Full Text] [Related]
15. Dynamic contrast-enhanced MRI of the microenvironment of pancreatic adenocarcinoma xenografts.
Wegner CS; Hauge A; Gaustad JV; Andersen LMK; Simonsen TG; Galappathi K; Rofstad EK
Acta Oncol; 2017 Dec; 56(12):1754-1762. PubMed ID: 28661213
[TBL] [Abstract][Full Text] [Related]
16. Correlation of dynamic contrast-enhanced MRI perfusion parameters with angiogenesis and biologic aggressiveness of rectal cancer: Preliminary results.
Yeo DM; Oh SN; Jung CK; Lee MA; Oh ST; Rha SE; Jung SE; Byun JY; Gall P; Son Y
J Magn Reson Imaging; 2015 Feb; 41(2):474-80. PubMed ID: 24375840
[TBL] [Abstract][Full Text] [Related]
17. Quantifying angiogenesis in VEGF-enhanced tissue-engineered bladder constructs by dynamic contrast-enhanced MRI using contrast agents of different molecular weights.
Cheng HL; Wallis C; Shou Z; Farhat WA
J Magn Reson Imaging; 2007 Jan; 25(1):137-45. PubMed ID: 17139634
[TBL] [Abstract][Full Text] [Related]
18. DCE-MRI of patient-derived xenograft models of uterine cervix carcinoma: associations with parameters of the tumor microenvironment.
Hauge A; Wegner CS; Gaustad JV; Simonsen TG; Andersen LMK; Rofstad EK
J Transl Med; 2017 Nov; 15(1):225. PubMed ID: 29100521
[TBL] [Abstract][Full Text] [Related]
19. DCE-MRI and Quantitative Histology Reveal Enhanced Vessel Maturation but Impaired Perfusion and Increased Hypoxia in Bevacizumab-Treated Cervical Carcinoma.
Hauge A; Gaustad JV; Huang R; Simonsen TG; Wegner CS; Andersen LMK; Rofstad EK
Int J Radiat Oncol Biol Phys; 2019 Jul; 104(3):666-676. PubMed ID: 30858145
[TBL] [Abstract][Full Text] [Related]
20. AG-013736, a novel inhibitor of VEGF receptor tyrosine kinases, inhibits breast cancer growth and decreases vascular permeability as detected by dynamic contrast-enhanced magnetic resonance imaging.
Wilmes LJ; Pallavicini MG; Fleming LM; Gibbs J; Wang D; Li KL; Partridge SC; Henry RG; Shalinsky DR; Hu-Lowe D; Park JW; McShane TM; Lu Y; Brasch RC; Hylton NM
Magn Reson Imaging; 2007 Apr; 25(3):319-27. PubMed ID: 17371720
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
